Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Drugs - Real World Outcomes
|
October 28, 2025
Sodium Zirconium Cyclosilicate Duration and Hyperkalemia-Related Healthcare Encounters in Patients with Heart Failure and Cardio/Renal Dysfunction: The GALVANIZE Outcome Study
Abiy Agiro, Fan Mu, Erin E Cook, et al.
Journal of Managed Care & Specialty Pharmacy
|
August 5, 2024
Economic burden of recurrent hyperkalemia in patients with chronic kidney disease
George Bakris, Abiy Agiro, Alexandra Greatsinger, et al.
Advances in Therapy
|
June 18, 2025
Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study
Abiy Agiro, Ali Greatsinger, Fan Mu, et al.
Advances in Therapy
|
March 18, 2026
The Burden, Outcomes, and Management of Patients with Aldosterone Dysregulation: A Targeted Literature Review
Gianfranco Parati, Gbenga Ogedegbe, Abiy Agiro, et al.
Journal of Women'S Health (2002)
|
July 11, 2017
Postpartum Emergency Department Visits and Inpatient Readmissions in a Medicaid Population of Mothers
Deborah B Ehrenthal, Katie Gelinas, David A Paul, et al.
BMC Nephrology
|
January 19, 2023
Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia
Eiichiro Kanda, Anjay Rastogi, Toyoaki Murohara, et al.
Journal of the American Heart Association
|
December 24, 2024
Hyperkalemia and the Risks of Adverse Cardiovascular Outcomes in Patients With Chronic Kidney Disease
Abiy Agiro, Fan Mu, Erin Cook, et al.
JACC. Advances
|
January 1, 2025
Consequences of Recurrent Hyperkalemia on Cardiovascular Outcomes and Mortality
George Bakris, Abiy Agiro, Fan Mu, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 28, 2022
Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I study
Charles V Pollack, Abiy Agiro, Fan Mu, et al.
Journal of Clinical Medicine
|
July 29, 2023
Liver Disease Is a Risk Factor for Recurrent Hyperkalemia: A Retrospective Cohort Study
Rebecca S Ahdoot, Jui-Ting Hsiung, Abiy Agiro, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Drugs - Real World Outcomes
|
October 28, 2025
Sodium Zirconium Cyclosilicate Duration and Hyperkalemia-Related Healthcare Encounters in Patients with Heart Failure and Cardio/Renal Dysfunction: The GALVANIZE Outcome Study
Abiy Agiro, Fan Mu, Erin E Cook, et al.
Journal of Managed Care & Specialty Pharmacy
|
August 5, 2024
Economic burden of recurrent hyperkalemia in patients with chronic kidney disease
George Bakris, Abiy Agiro, Alexandra Greatsinger, et al.
Advances in Therapy
|
June 18, 2025
Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study
Abiy Agiro, Ali Greatsinger, Fan Mu, et al.
Advances in Therapy
|
March 18, 2026
The Burden, Outcomes, and Management of Patients with Aldosterone Dysregulation: A Targeted Literature Review
Gianfranco Parati, Gbenga Ogedegbe, Abiy Agiro, et al.
Journal of Women'S Health (2002)
|
July 11, 2017
Postpartum Emergency Department Visits and Inpatient Readmissions in a Medicaid Population of Mothers
Deborah B Ehrenthal, Katie Gelinas, David A Paul, et al.
BMC Nephrology
|
January 19, 2023
Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia
Eiichiro Kanda, Anjay Rastogi, Toyoaki Murohara, et al.
Journal of the American Heart Association
|
December 24, 2024
Hyperkalemia and the Risks of Adverse Cardiovascular Outcomes in Patients With Chronic Kidney Disease
Abiy Agiro, Fan Mu, Erin Cook, et al.
JACC. Advances
|
January 1, 2025
Consequences of Recurrent Hyperkalemia on Cardiovascular Outcomes and Mortality
George Bakris, Abiy Agiro, Fan Mu, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 28, 2022
Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I study
Charles V Pollack, Abiy Agiro, Fan Mu, et al.
Journal of Clinical Medicine
|
July 29, 2023
Liver Disease Is a Risk Factor for Recurrent Hyperkalemia: A Retrospective Cohort Study
Rebecca S Ahdoot, Jui-Ting Hsiung, Abiy Agiro, et al.
Page
of 5